Skip to main content
SpringerLink
Log in

Huntington disease: Advances in molecular and cell biology

  • Published:
Journal of Inherited Metabolic Disease

Abstract

Huntington disease is an inherited neurodegeneration, for which the associated mutation was isolated in 1993. The mutation is an expansion of a CAG trinucleotide repeat, which translates to give a polyglutamine tract at the N-terminus of a large protein, huntingtin. Neither the normal nor the pathogenic functions of this protein have been identified, but it is clear that pathogenesis is mediated through the expanded polyglutamine tract within the protein, and that polyglutamine is toxic to cells. A number of proteins which interact with the N-terminal region of huntingtin have been isolated, but this has not, so far, yielded a rationale for pathogenesis. Huntingtin is found in areas of the brain that degenerate in this disease, but is also associated with pathogenic inclusions in Alzheimer disease and Pick disease. It is possible that Huntington disease has pathogenic mechanisms in common with these other neurodegenerative diseases, and that the mechanism may relate to the formation of abnormal, cytoskeletal-associated, inclusions within cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  • Ambrose CM, Duyao MP, Barnes G, et al (1994) Structure and expression of the Huntington's disease gene: evidence against simple inactivation due to an expanded CAG repeat. Somat Cell Mol Genet 20: 27–38.

    Google Scholar 

  • Andrew SE, Goldberg YP, Kremer B, et al (1993) The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nature Genet 4: 398–403.

    Google Scholar 

  • Arai H, Lee VM-Y, Otvos Jr L, et al (1990) Defined neurofilament, τ, and β-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques. Proc Natl Acad Sci USA 87: 2249–2253.

    Google Scholar 

  • Aronin N, Chast K, Young C, et al (1995) CAG expansion affects the expression of mutant huntingtin in the Huntington's disease brain. Neuron 50: 1193–1201.

    Google Scholar 

  • Aslanidis C, Jansen G, Amemiya C, et al (1992) Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature 355: 548–551.

    Google Scholar 

  • Bao J, Sharp AH, Wagster MV, et al (1996) Expansion of poly-glutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Proc Natl Acad Sci USA 93: 5037–5042.

    Google Scholar 

  • Barnes GT, Duyao MP, Ambrose CM, et al (1994) Mouse Huntington's disease homologue (hdh). Somat Cell Moll Genet 20: 27–38.

    Google Scholar 

  • Beal MF (1995) Aging, energy and oxidation in neurodegenerative diseases. Ann Neurol 38: 357–366.

    Google Scholar 

  • Blass JP (1993) Pathophysiology of the Alzheimer's syndrome. Neurology 43: S25–S38.

    Google Scholar 

  • Burke JR, Enghild JJ, Martin ME, et al (1996) Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Med 2: 347–350.

    Google Scholar 

  • Burright EN, Clark HB, Servadio A, et al (1995) SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell 82: 937–948.

    Google Scholar 

  • Buxton J, Shelbourne P, Davies J, et al (1992) Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 355: 547–548.

    Google Scholar 

  • Cammarata S, Caponnetto C, Tabaton M (1993) Ubiquitin-reactive neurites in cerebral cortex of subjects with Huntington's chorea: a pathological correlate of dementia? Neurosci Lett 156: 96–98.

    Google Scholar 

  • Campuzano V, Montermini L, Molto MD, et al (1996) Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271: 1423–1427.

    Google Scholar 

  • Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate and neurodegenerative disorders. Science 262: 689–695.

    Google Scholar 

  • DiFiglia M, Sapp E, Chase K, et al (1995) Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14: 1075–1081.

    Google Scholar 

  • Duyao M, Ambrose C, Myers R, et al (1993) Trinucleotide repeat length instability and age of onset in Huntington's disease. Nature Genet 4: 387–392.

    Google Scholar 

  • Fischbeck K H (1997) Kennedy disease. J. Inher. Metab. Dis. 20: 152–158.

    Google Scholar 

  • Goldberg YP, Kalchman MA, Zeisler J, et al (1996) Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the Huntington's disease transcript. Hum Mol Genet 5: 177–185.

    Google Scholar 

  • Green H (1993) Human genetic diseases due to codon reiteration: relationship to an evolutionary mechanism. Cell 74: 955–956.

    Google Scholar 

  • Gutekunst EA, Levey AI, Heilman CJ, et al (1995) Identification and localisation of huntingtin in brain and human lymphoblastoid cell lines with antifusion protein antibodies. Proc Natl Acad Sci USA 92: 8710–8714.

    Google Scholar 

  • Hardy JA, Higgins GA (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256: 184–185.

    Google Scholar 

  • Harley HG, Brook JD, Rundle SA, et al (1992) Expansion of an unstable DNA region and phenotype variation in myotonic dystrophy. Nature 355: 545–546.

    Google Scholar 

  • Harper PS (1996a) The natural history of Huntington's disease. In Harper PS, ed. Huntington's Disease, 2nd edn. London: WB Saunders, 123–136.

    Google Scholar 

  • Harper PS (1996b) The epidemiology of Huntington's disease. In Harper PS, ed. Huntington's Disease, 2nd edn. London: WB Saunders, 201–240.

    Google Scholar 

  • Harper PS, Morris M (1996) Introduction: a historical background to Huntington's disease. In Harper PS, ed. Huntington's Disease, 2nd edn. London: WB Saunders, 1–30.

    Google Scholar 

  • Harper PS, Soldan J, Tyler A (1996) Predictive tests in Huntington's disease. In Harper PS, ed. Huntington's Disease, 2nd edn. London: WB Saunders, 359–394.

    Google Scholar 

  • Hirst MC, Barnicoat A, Flynn G, et al (1993) The identification of a third fragile site, FraxF, in Xq27–q28 distal to both FraxA and FraxE. Hum Mol Genet 2: 197–200.

    Google Scholar 

  • Huitorel P, Pantaloni D (1985) Bundling of microtubules by glyceraldehyde 3-phosphate dehydrogenase and its modulation by ATP. Eur J Biochem 150: 265–269.

    Google Scholar 

  • Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72: 971–983.

    Google Scholar 

  • Ikeda H, Yamaguchi M, Sugai S, Aze Y, Narumiya S, Kakizuka A (1996) Expanded polyglutamine in the Machado — Joseph disease protein induces cell death in vitro and in vivo. Nature Genet 13: 196–202.

    Google Scholar 

  • Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y (1994) Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 13: 45–53.

    Google Scholar 

  • Johnson JW, Ascher P (1990) Voltage-dependent block by intracellular Mg2+ of N-methyl-D-aspartate-activated channels. Biophys J 57: 1085–1090.

    Google Scholar 

  • Jou Y-S, Myers RM (1995) Evidence from antibody studies that the CAG repeat in the Huntington disease gene is expressed in the protein. Hum Mol Genet 4: 465–469.

    Google Scholar 

  • Kalchman MA, Graham RK, Xia G, et al (1996) Huntingtin is ubiquinated and interacts with a specific ubiquitin-conjugating enzyme. J Biol Chem 271: 19385–19394.

    Google Scholar 

  • Keates RAB (1984) Microtubule-associated proteins in microtubule preparations made with and without glycerol. Can J Biochem Cell Biol 62: 803–813.

    Google Scholar 

  • Knight SJL, Flannery AV, Hirst MC, et al (1993) Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell 74: 127–134

    Google Scholar 

  • Koshy B, Matilla T, Burright EN, et al (1996) Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. Hum Mol Genet 5: 1311–1318.

    Google Scholar 

  • Kosik KS, Joachim CL, Selkoe DJ (1986) Microtubule-associated protein Tau (τ) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci USA 83: 4044–4048.

    Google Scholar 

  • Landwehrmeyer GB, McNeil SM, Dure LS, et al (1995) Huntington's disease gene: regional and cellular expression in brain of normal and affected individuals. Ann Neurol 37: 218–230.

    Google Scholar 

  • Li X-J, Li S-H, Sharpe AH, et al (1995) A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378: 398–402.

    Google Scholar 

  • Li X-J, Sharp AH, Li S-H, Dawson TM, Snyder SH, Ross CA (1996) Huntingtin-associated protein (HAP1): discrete neuronal localisations in the brain resemble those of neuronal NO synthase. Proc Natl Acad Sci USA 93: 4839–4844.

    Google Scholar 

  • Lin B, Nasir J, MacDonald H, et al (1994) Sequence of the murine Huntington disease gene: evidence for conservation, alternate splicing and polymorphism in a triplet (CCG-repeat). Hum Mol Genet 3: 85–92.

    Google Scholar 

  • Love S, Saitoh T, Quijada S, Cole GM, Terry RD (1988) Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies. J Neuropathol Exp Neurol 47: 1–8.

    Google Scholar 

  • MacMillan J, Quarrel O (1996) The neurobiology of Huntington's disease. In Harper PS, ed. Huntington's Disease, 2nd edn. London: WB Saunders, 317–357.

    Google Scholar 

  • Mandel J-L, Heitz D (1992) Molecular genetics of the fragile-X syndrome: a novel type of unstable mutation. Curr Opin Genet Dev 2: 422–430.

    Google Scholar 

  • Mangiarini L, Sathisivam K, Seiler M, et al (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 87: 493–506.

    Google Scholar 

  • Neal JW, Fenton I, MacMillan JC, et al (1994) A study comparing mutation triplet repeat size and phenotypes in patients with Huntington's disease. Neurodegeneration 3: 73–77.

    Google Scholar 

  • Nicholls D, Atwell D (1990) The release and uptake of excitatory amino acids. Trends Pharmacol Sci 11: 462–468.

    Google Scholar 

  • Perutz M (1994) Polar zippers — their role in human disease. Protein Sci 3: 1629–1637.

    Google Scholar 

  • Perutz MF, Johnson T, Suzuki M, Finch JT (1994) Glutamine repeats as polar zippers: their possible role in inherited neuropsychiatric diseases. Proc Natl Acad Sci USA 91: 5355–5358.

    Google Scholar 

  • Robbins AR, Ward RD, Oliver C (1995) A mutation in glyceraldehyde 3-phosphate dehydrogenase alters endocytosis in CHO cells. J Cell Biol 130: 1093–1104.

    Google Scholar 

  • Roses AD (1994) Apolipoprotein E affects the rate of Alzheimer disease expression: β-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol 53: 429–437.

    Google Scholar 

  • Ross CA (1995) When more is less: pathogenesis of glutamine repeat neurodegenerative diseases. Neuron 15: 493–496.

    Google Scholar 

  • Rubinsztein DC, Leggo J, Coles R, et al (1996) Phenotypic characterisation of individuals with 30–40 CAG repeats in the Huntington's disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36–39 repeats. Am J Hum Genet 58: 16–22.

    Google Scholar 

  • Schilling G, Sharp AH, Loer SJ, et al (1995) Expression of the Huntington's disease (IT15) protein product in HD patients. Hum Mol Genet 4: 1365–1371.

    Google Scholar 

  • Schmitt I, Bachner D, Megow D, et al (1995) Expression of the Huntington disease gene in rodents: cloning of the rat homologue and evidence for downregulation in non-neuronal tissues during development. Hum Mol Genet 4: 1173–1182.

    Google Scholar 

  • Schulze H, Schuler A, Stuber D, Dobeli H, Langen H, Huber G (1993) Rat brain glyceraldehyde-3-phosphate interacts with the recombinant cytoplasmic domain of Alzheimer's β-amyloid precursor protein. J Neurochem 60: 1915–1922.

    Google Scholar 

  • Sharp AH, Loer SJ, Schilling G, et al (1995) Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 14: 1065–1074.

    Google Scholar 

  • Siegler KM, Mauro DJ, Seal G, et al (1991) A human nuclear uracil DNA glycosylase is the 37kDa subunit of glyceraldehyde 3-phosphate dehydrogenase. Proc Natl Acad Sci USA 88: 8460–8464.

    Google Scholar 

  • Snell R, MacMillan JC, Cheadle JP, et al (1993) Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nature Genet 4: 393–397.

    Google Scholar 

  • Stott K, Blackburn JM, Butler PJG, Perutz M (1995) Incorporation of glutamine repeats makes protein oligomerise: implications for neurodegenerative diseases. Proc Natl Acad Sci USA 92: 6509–6513.

    Google Scholar 

  • Strong TV, Tagle DA, Valdes JM, et al (1993) Widespread expression of the human and rat Huntington's disease gene in brain and non-neural tissues. Nature Genet 5: 259–265.

    Google Scholar 

  • Trottier Y, Didier D, Imbert G, et al (1995a) Cellular localisation of the Huntington's disease protein and discrimination of the normal and mutated form. Nature Genet 10: 104–110.

    Google Scholar 

  • Trottier Y, Lutz Y, Stevaniu G, et al (1995b) Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 378: 403–406.

    Google Scholar 

  • van Broekhoven C (1995) Molecular genetics of Alzheimer disease: identification of genes and mutations. Eur Neurol 35: 8–19.

    Google Scholar 

  • Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP (1985) Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44: 559–577.

    Google Scholar 

  • Wang J-Z, Grundke-Iqbal I, Iqbal K (1996) Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease. Nature Med 2: 781–875.

    Google Scholar 

  • Watkins JC, Krogsgaard P, Honore T (1990) Structure—activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. Trends Pharmacol Sci 11: 25–33.

    Google Scholar 

  • Wood J, MacMillan JC, Harper PS, et al (1996) Partial characterisation of murine huntingtin and apparent variation in the subcellular localisation of huntingtin in human, mouse and rat brain. Hum Mol Genet 5: 481–487.

    Google Scholar 

  • Yasuhara O, Matsuo A, Tooyama I, Kimura H, McGeer EG, McGeer PL (1995) Pick's disease immunohistochemistry: new alterations and Alzheimer's disease comparisons. Acta Neuropathol 89: 322–330.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Medical Genetics, University of Wales College of Medicine, Heath Park, Cardiff, CF4 4XN, UK

    A. L. Jones, J. D. Wood & P. S. Harper

Authors
  1. A. L. Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. D. Wood
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. S. Harper
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jones, A.L., Wood, J.D. & Harper, P.S. Huntington disease: Advances in molecular and cell biology. J Inherit Metab Dis 20, 125–138 (1997). https://doi.org/10.1023/A:1005340302695

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005340302695

Keywords

Search

Navigation